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The purpose of this study was to analyze the effects of the drug, 
flurazepam dihydrocloride on the growth and motility of Tetrahymena 
pyriformis maintained under axenic conditions. 
Growth cultures containing the drug and the organisms were 
cultivated at 26°C for five days, with optical readings taken at 24-hr 
intervals. These readings were determined by turbidity using a 
Spectronic 20. The organisms were examined by Scanning Electron Micro-
scopy to determine sites of drug activity on the organisms. Results 
revealed that flurazepam dihydrocloride caused the inhibition of growth 
and motility of l· pyriformis. Scanning Electron Microscope studies 
revealed that the primary sites of activity of T. pyriformis are upon 
(1) the cilia, preventing motility making the organism unable to reach 
its food, (2) the buccal cavity, hendering the oral apparatus that also 
has cilia, and (3) the pellicle, comprising the outer membrane of the 
organism, which is destroyed. 
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Tetrahymena pyriformis, a pear-shaped, freshwater, ciliated 
organism, approximately 50 lJil1 in length and 30 lJil1 in width, has been 
used as a model system in many 1 aboratori es to study a variety of 
biological phenomena such as cell division, cell synchrony, structure of 
cilia, cilia genetics, cortical patterns, and membrane biosynthesis. 
Flurazepam dihydrochloride, 7-chloro-1-L2-(diethylamino) ethylj-5-
(o-flurophenyl)-1, 3-dihydro-2H-1, 4-benzodiazepin-2-one dihydrochlo-
ride, (Figure 1) is a member of the group of drugs called benzodiaze-
pines. It is a pale yellow, crystalline compound, freely soluble in 
U.S.P. alcohol and very soluble in water. Flurazepam dihydrochloride 
(most commonly known as 11 da 1 mane .. ), one of the benzodi azepi nes specifi-
cally marketed as a hypnotic, is quickly metabolized by the liver to 
1-desalkyl flurazepam. However, 1-desalkyl flurazepam is more potent in 
animals than flurazepam dihydrochloride (Randall, et al. 1969). In man, 
chronic administration of flurazepam dihydrochloride leads to the 
accumulation of 1-desalkyl flurazepam for about 7 to 10 days. This 
kinetic pattern is similar to that found with benzodiazepines used 
exclusively as anxiolytic agents (Beimer, 1977). 
This present study is concerned with the cellular action of 
flurazepam dihydrochloride on the growth and motility of the protozoan, 
Tetrahymena pyriformis with the following objectives: 1) to observe the 
physiological and cellular effects of flurazepam dihydrochloride on 
1 
2 
Jl. pYriformis; 2) to determine whether or not this drug affects the uni-
cellular organism on the ultrastructural level. The growth observations 
will attempt to determine (1) the degree of structural destruction of 
the cellular membrane, and (2) the effects the drug will have on food 
vacuoles with respect to food ingestion and egestion. The motility 
observations will attempt to determine (1) the rate of movement of the 
cilia under varied concentrations of the drug, and (2) the time it takes 
for a complete immobilization to occur using the same concentrations. 
Manifestations of dalmane overdosage include somnolence, confusion 
and coma. Respiration, pulse and blood pressure should be monitored. 
General supportive measures should be employed, along with immediate 
gastric lavage. Intravenous fluids should be administered and an 
adequate airway maintained. Hypotension and Central Nervous System 
(CNS) depression may be combated by judicious use of appropriate 
therapeutic agents. The value of dialysis has not been determined. If 
excitation occurs in patients following dalmane (flurazepam dihydro-
chloride) overdosage, barbiturates should not be used since multiple 
agents may have been ingested (Physicians• Desk Reference 38th ed., 
1984). 
Tetrahymena pyriformis in this type of study is useful because it 
has been shown that Jl. pyriformis is an exceptionally useful subject for 
studying metabolic interrelationships among intracellular membranes 
(Thompson, 1972). It has also been reported that Tetrahymena, in its 
nutrition, morphology and reproduction, is similar to a great number of 
eukaryotes including higher vertebrates (Hill, 1972; Kudo, 1972). 






REVIEW OF LITERATURE 
The fluidity of a biological membrane is widely acknowledged to be 
of great importance in controlling the metabolic functions of that 
membrane and is primarily a function of (1) lipid composition of the 
membrane, and (2) the environmental factors, for example, temperature, 
pH, and ionic strength affecting the membrane at any given time. 
The ciliate Tetrahymena pYriformis has been used extensively as a 
model system to study the response of the membrane to temperature 
changes (Martin, C.E. et al., 1976., Fukushima et al., 1976, Thompson, 
1983). 
Cilia of Tetrahymena provide a homogenous system capable of 
responding to stress via molecular changes in species, yet apparently 
lacking other key enzymatic mechanisms such as those catalyzing fatty 
acid desaturation and polar head group alterations, that have been 
implicated in lipid fluidity alteration (Ramesha, C.S. et al, 1983). 
The pellicle of oral ribs, located on the right side of the oral 
cavity of the organism, is where the food vacuoles form and pinch off 
into the cell (Sattler and Staehelin, 1976). The oral ribs are 
delineated on their outer surface by the plasma membrane. Each rib 
contains six microtubules arranged in two rows; two microtubules in one 
row and four microtubules in the other. The alveolar sacs are arranged 
in the form of long tubes which underline the plasma membrane and runs 
parallel to the ribs between the row of four microtubules of one rib, 
4 
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and the two of two mi crotubul es in the adjacent rib, (Satt 1 er and 
Staehelin, 1979). 
Nozawa et al., (1979) stated that Tetrahymena pyriformis strain 
WH-14, grown in medium supplemented with ergosterol (1 mg/100 ml }, lead 
to profound alterations in phospholipid components of the cell membrane. 
The behavior and ultrastructure of Tetrahymena pyriformis was 
assessed after exposure to dosages of 8% and 16% of the lethal concen-
tration of mercury chloride (HgC1 2). The lower dosage caused no 
abnormal changes in cell motility, in activity of the water expulsion 
vesicles, or in the cell shape. The higher dosage caused deleterious 
changes in these parameters. The higher sub 1 etha 1 HgC1 2 concentration 
(.5 mg/liter), elicited the damage of several cell structures 
(Tingle, L. et al., 1973). 
Grim et al., 1980, removed the outer limiting membranes (the pelli-
cle), through revealing the geometry of the microtubules; which lie at 
the outer boundary of the ectoplasm, which is useful in the analysis of 
their organization and functions. It has been shown Grim's membrane 
removal method provides a better perspective of some sub-pelliculiar 
microtubules than other methods previously available. This method will 
in turn facilitate research on possible cause-and-effect relationships 
between microtubules and certain membrane components and changes in cell 
form and shape (Staller and Staehelin, 1975). 
Cytotoxic effects of acridine, an organic component of synthetic 
fossil fuel products, were investigated. Populations of the common 
freshwater ciliate, Tetrahymena pyriformis, were exposed to various 
6 
concentrations from 0 to 40 mg Liter-1 where their behavior, 
respiration, cytology, and growth were examined. The 24-hr Lc
180 
and 
24-hr LC50 were determined to be 35 and 30 mg Liter-
1 respectively. At 
lower concentrations, few if any sublethal alterations were noted in 
respiration, ultrastructure, cell size, and glycogen and protein 
contents. However, at 30 mg Liter-1, cell size and glycogen content are 
significantly reduced. In contrast, population growth is altered at 
concentrations as low as 2.5 mg Liter-1• This is the most striking 
toxic response to acridine preceded by shape alteration and contractile 
vacuole malfunction. Cytolysis may result from a weakened membrane and 
pellicle by the partitioning of the hydrophyllic acridine into highly 
lipid membranes (Shultz, et al., 1981). 
The oral apparatus of Tetrahymena pyriformis is an organelle 
composed of cil1ated and nonciliated basal bodies interconnected by a 
network of microtubules and filaments. Potassium chloride (KCl) 
extraction of the isolated oral apparatus resulted in the selective 
solubilization of oral apparatus basal bodies with remnants of ciliary 
axonemes and fused body basal plants. Based on their response to KCl 
extraction, two distinct sets of morphologically similar microtubules 
can be identified; (a) microtubules which constitute the internal 
structure of basal bodies and ciliary axonemes, and (b) microtubules 
which constitute fiber connectives between basal bodies (Gavin, 1977). 
Several studies have demonstrated that microtubules differ in their 
stability and response to various agents. For example, cilia and 
centrioles were stable to treatments which disrupted cytoplasmic 
7 
microtubules (Tilney, L.G. et al., 1973); mitotic microtubules in amoeba 
differed in respect to conditions which inhibited their reformation 
following disruption by temperature (Roth, L.E., 1967). 
Many compounds of the 1-4-benzodiazepines series display tranquil-
izing, muscle-relaxant, anti-convulsant and sedative effects. The 
discovery that the first two members of this family of compounds, 
chlordiazepoxide and diazepam (valium), have useful pharmacological 
properties in experimental animals led to their extensive investigation 
(Sternbach et al., 1964). Today many benzodiazepines are widely used as 
daytime sedatives, tranquilizers, and sleep inducers (Randall et al., 
1974). 
Based on the data, close examination of the basic pharmacologic 
properties of benzodiazepines reveals that numbers 1-, 4-benzodiapine 
can be selected exclusively as a hypnotic agent in perference to any 
other benzodiazepines (Greenblatt et al., 1973). Despite this conclu-
sion, many benzodiazepines are specifically promoted as sleep inducers, 
whereas others are positioned specifically as anticonvulsants or alter-
natively as anti-anxiety agents. Even pharmacokinetic properties fail 
to distinguish between benzodiazepines. It might be argued that 
benzodiazepines are quickly detoxified and excreted making them suitable 
as hypnotics (Randall et al., 1973). 
Dalmane is a hypnotic agent useful in all types of insomnia 
chracterized by difficulty in falling to sleep, frequent nocturnal 
awakenings and/or early morning awakening. Dalmane can be used 
effectively in patients with recurring insomnia or poor sleeping habits, 
8 
and in acute or chronic medical situations requiring restful sleep. 
Since insomnia is often transient and intermittent, the prolonged 
administration of dalmane is generally not necessary or recommended 
(Physicians• Desk Reference, 38th ed., 1984). 
In animal studies, flurazepam dihydrochloride reduced the pressor 
response to electrical stimulation of the hypothalamus, and increased 
the arousal threshold to stimulation of the amygdala and hypothalamus; 
however, the exact site and mode of action are unknown (Physicians• Desk 
Reference, 38th ed., 1984). 
The pharmaco 1 ogy of flu raze pam di hydroch 1 ori de has been reviewed 
extensively by many scientists. Greenblatt, et al., (1975) and 
Greenblatt, (1978) stated that in animal studies it shares muscle 
relaxant and anti-convulsant properties with other benzodiazepines 
although less potentially than diazepam and very roughly with equipo-
tence to chlorodiazepoxide. However, in other measures there are some 
differences, although a variety of benzodiazepines increase exploratory 
behavior in mice, flurazepam dihydrochloride does not (Nolan & Parks, 
1973). A common test of possible anxiolytes is either their ability to 
restore behaviors which have been decreased by noxious stimuli, or to 
reduce behaviors stimulated by noxious stimuli. Although both 
flurazepam dihydrochloride and chlorodiazepoxide share the latter 
property, doses necessary for such actions by flurazepam dihydrochloride 
were close to those which produce motor deficits (Randall et al., 
1969). In the immobilized cat, a variety of benzodiazepines differ in 
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quantitative and qualitative ways in animal studies, although clinical 
importance of these differences is uncertain. 
Flurazepam dihydrochloride is rapidly absorbed after oral 
administration, and distributed evenly through the body. Although 
diazepam, chlorodiazepoxide and nitrazepam bind serum albumin 
thoroughly, flurazepam dihydrochloride may be relatively weakly bound 
(Miller & Wolbert, 1973). A study in which 28 mg of 14c-labeled 
flu razepam di hydroch 1 ori de was administered to 2 human subjects 
indicates that peak concentration of labeled material appeared 1 hr 
after ingestion (Schwartz & Postma, 1970). It was only at that time 
that the parent component could be detected, which represented only 1% 
of the total plasma 14c, indicating the rapid metabolism of flurazepam 
dihydrochloride. Approximately half of the labeled material was 
recovered in the urine in the first 24 hr. After 98 hr, 81% of the 
total label was found in the urine and 8 to 9% in the feces. The 
hydroxyethal metabolite conjugated to the glucloronide or sulfate, 
comprised 22 to 25% of urinary radioactivity. A study of spectrophoto-
flurometric analyses of blood on urine from 2 volunteers was performed 
after administration of 90 mg of unlabeled flurazepam dihydrochloride. 
Peak levels of the parent compound were found after 1 hr, but these 
quantities were substantially smaller than the two major metabolites (de 
Silva & Strojny, 1971). 
The effect of benzodiazepines on the sleep pattern are similar to 
those of barbiturates. Both benzodi azepi nes and barbiturates decrease 
body movement, the number of awakenings, sleep latency (the time 
10 
required to fall asleep}, total rapid eye movement (REM) sleep, and the 
number of shifts in sleep stages. They both increase total sleep, stage 
2 sleep, and fast activity (a activity) in the electroencephalogram 
(EEG) (Kay et al., 1976; Hauri, et al., 1983). Benzodiazepines may 
decrease stages 3 and 4 of sleep more than barbiturates, but these 
reports will have to be confirmed. A possible advantage of some 
benzodiazepines, especially that of flurazepam dihydrochloride, appears 
to be that their hypnotic efficacy persists during long-term 
administration. When compared to barbiturates and other hypnotics in 
short-term studies, benzodiazepines are equally effective and likely to 
produce hangover and persistent psychomotor impairment (Hartman, 1975; 
Cummiskey, et al., 1983) A major advantage of benzodiazepines is their 
relative safety. Fatalities due to benzodiazepine overdosage alone are 
rare. When taken together with other drugs, i ntoxi cation probably 
depends largely on the type and quantity of non-benzodiazepines 
(Greenblatt, et al., 1977). Benzodiazepines do not cause significant 
enzyme induction in man, and therefore tend to interact with other less 
frequently than do barbiturates. 
The disadvantage of benzodiazepines appears to the slowness of 
their elimination. Drug-induced abnormalities in the EEG; hangover 
effects, impairment of psychomotor performance, and ability to fall 
asleep, persist longer with nitrazepam than with sodium amobarbital 
(Oswald, 1973). Both benzodiazepines and barbiturates produce rebound 
abnormalities on withdrawl, with patients spending a disproportionate 
amount of time in REM sleep with increased intensity. It must be 
11 
concluded that a prescription for long term hypnotic use is rarely 
indicated. 
CHAPTER III 
MATERIALS AND METHODS 
Axenic cultures of Tetrahymena pyriformis were obtained from the 
Carolina Biological Supply Company, Burlington, North Carolina. 
Tetrahymena were maintained in a medium of proteose petone that was 
recommended by the Carolina Biological Supply Company. The ingredients 
of this medium are supplied in Table I. 
The growth of Tetrahymena pyriformis is affected by light, 
therefore they were kept at 28°C in the dark. Photo-periodic effects on 
Tetrahymena pyriformis were demonstrated by Willie et al., 1968. 
One liter of the medium was dispensed into eight 500 ml erylenmeyer 
flasks in quantities of 125 ml per flask. The growth medium was then 
autoclaved for 10 to 15 min at 141 lb/in2 pressure and 121 oc. It has 
been recommended that a reduced time of 10 to 15 min instead of 20 min 
of autoclaving be used to prevent the breakdown of components such as 
peptone and tryptone (Prescott, 1972). After the medium was cooled, it 
was inoculated with Tetrahymena pyriformis and placed at 26°C in a 
covered stationary water bath. 
Sterile conditions were used in the experimental procedures. To 
test for contamination of bacteria, the suspected contaminated flasks 
were inoculated with 1 g of streptomycin sulfate; before adding the 
streptomycin to the flask, the Tetrahymena pyriformis was streaked on a 
nutrient agar plate. After inoculating the media, an aliquot was 
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contamination with streptomycin in it, is then streaked on a nutrient 
agar plate. Periodic tests of the same nature were performed to insure 
that there was no more contamination. 
The drug, flurazepam dihydrochloride (lot# 007058) was obtained 
from the Roche Laborabory, New Jersey. The drug was diluted to severa 1 
concentrations and stored as stock dilutions at 4°C. Drug dilution 
concentrations are in Table II. 
Growth study procedures were carried out by transferring 
Tetrahymena pYriformis to fresh medium every 48 hrs, which was during 
log phase. After cells were transferred, they were placed into 
13 x 150 mm test tubes; at a ratio of 1:3:1 (1 ml of Tetrahymena 
pyriformis: 3 ml of fresh media: 1 ml of the individual drug concentra-
tions). The control test tube contained 4 ml of fresh medium with 1 ml 
of the organism. There were three experimental test tubes for each drug 
con cent ration used. These tubes were placed at 28°C in the covered 
water bath. Growth study readings were made every 24 hrs for 5 days. 
These studies were carried out using a Spectronic 20 spectrophotometer 
(Bausch & Lomb) at 540 nm according to the method of Durojaiye (1979; 
1981). 
Motility studies were observed using 0.1 ml of Tetrahymena 
pYriformis and 0.1 ml of the drug concentrations. The experimental 
tubes were placed in a counting chamber and observed under a 1 i ght 
microscope for 60 mins at 5-min intervals for each drug concentration. 
15 
Table II 
Drug Concentrations mg/ml 
mg ml F1nal Concentration 
1 1 25 t 1000 = .03 mg/ml (. 025) 
2 3 25 t 1000 = .08 mg/ml (.075) 
3 5 25 t 1000 = .13 mg/ml (.125) 
4 7 25 t 1000 = .18 mg/ml (.175) 
5 9 25 t 1000 = .23 mg/ml (. 225) 
6 11 25 t 1000 = .28 mg/ml (. 275) 
7 13 25 t 1000 = .33 mg/ml (.325) 
8 15 25 t 1000 = .38 mg/ml (.375) 
9 17 25 t 1000 = .43 mg/ml ( .425) 
10 19 25 t 1000 = .48 mg/ml (.475) 
11 21 25 t 1000 = .53 mg/ml (.525) 
12 23 25 t 1000 = .58 mg/ml (.575) 
13 25 25 t 1000 = .63 mg/ml (.625) 
16 
The percent of immobilization of Tetrahymena pyriformis was determined 
by using the formula below: 
% immobilization 
Ultrastructural 
= total number of immobilized Tetrahymena x 100 
total number of Tetrahymena 1n count1ng chamber 
studies were performed by first pelleting the 
cells, then they were fixed at room temperature with 2% glutaraldehyde 
pH 7.2 for 1.5 to 2 hrs. Then the cells were then washed 3 times with 
2% sodium cacodylate buffer solution. After washing, they were post 
fixed with osmium tetraoxide for 1 hr, and were washed 3 times again, 
with 2% sodium cacodylate. After the last wash, they were run through a 
graded series of alcohol (ethanol) dehydrations: 25%, 50%, 75%, 90%, 
95% and 100%. Further dehydrations were carried out in a graded series 
of amylacetate dilutions. At this point, they were placed on studs and 
either left to air dry overnight under a closed hood or were dried with 
a critical-point dryer, after which the organisms were coated and ready 
for examination using the OMNISCAN Scanning Electron Microscope (SEM). 
CHAPTER IV 
EXPERIMENTAL RESULTS 
The tests outlined previously were designed to show the 
ultrastructural effects of flurazepam dihydrochloride on the growth and 
motility of Tetrahymena pyriformis. The information on Table III shows 
that there was a general stabilizing effect or a slight decrease in the 
growth of Tetrahymena pyriformis after a 5-day reading as the drug 
concentrations increased. The results on Table III are obtained from an 
average of three growth readings. Figures 2 through 14 are plotted as 
optical density against time for 120 hrs (5 days). The drug concentra-
tions are relatively close together, which give the stabilizing effects 
shown. 
The first reading in figures 2 through 14 were taken first at 
12 hrs, thereafter 24-hr readings were taken until 120 hrs was 
reached. Figure 2 shows the growth reading for the lowest drug 
con cent ration, .03 mg/ml. The 12-hr reading for this con cent ration 
shows a 4 nm difference between the experimental and the control. The 
24-hr reading shows an increase of 1 nm more to 5 nm. The 1 argest 
difference shown is at 48 hrs, where the difference is 8 nm. The last 
three readings show a constant difference of 6 nm. At this concentra-
tion {.03 mg/ml), there is a very short (if any) lag phase (12-24 hrs), 
a rapid log phase (48 hrs) appearance, and a constant stationary phase 
in the control. 
phase. 






Drug Concentrations 12 24 48 72 96 120 
1 .03 mg/ml .04 .03 .02 .02 .02 .02 
2 .08 mg/ml .04 .02 .01 .01 .01 .01 
3 .13 mg/ml .03 .01 .01 .01 .01 .01 
4 .18 mg/ml .04 .01 0 0 0 0 
5 • 23 mg/ml .05 .02 .002 0 .002 0 
6 .28 mg/ml .05 .002 .01 .01 .008 0 
7 .33 mg/ml .04 .02 .01 .01 .01 .01 
8 .38 mg/ml .06 .03 .02 .01 .02 .02 
9 .43 mg/ml .05 .02 .02 .03 .03 .02 
10 .48 mg/ml .04 .02 .03 .02 .02 .02 
11 .53 mg/ml .04 .02 .02 .03 .03 .01 
12 .58 mg/ml .05 .03 .03 .03 .03 .02 
13 .63 mg/ml .06 .03 .03 .03 .03 .03 
14 Control .08 .08 .10 .08 .08 .08 
FIG. 2 Growth of Tetrahymena pyriformis in 0.03 mg/ml Flurazepam 
















FIG. 3 Growth of Tetrahymena pyriformis in 0.08 mg/ml Flurazepam 
















The results of .08 mg/ml are shown in figure 3. The 12-hr 
difference is 4 nm, whereas the biggest difference comes at 48 hrs with 
the control being at .10 nm and the experimental .01 nm. The behavior 
of the organism at this concentration also shows a stationary phase 
after 48 hrs (48-120 hrs). 
Figure 4 gives the result of .13 mg/ml concentration of the drug. 
The 12-hr reading gives a difference of 5 nm with the control being 
.08 nm and the experimental being .03 nm. The largest difference being 
9 nm, which is reached at 48 hrs with the control being .10 nm and the 
experimental being .01 nm. This concentration also exhibits a station-
ary phase, which last slightly more than the previous concentration from 
24 hrs to 120 hrs. 
Readings for concentration .18 mg/ml are given in Figure 5. The 
first reading of 12 hrs shows a difference of 5 nm between the 
experiment a 1 and the control, with the control being .08 nm and the 
experimental being .04 nm. At 24 hrs, the difference increased to 
5 nm. At 48 hrs, the largest difference occurs with the control being 
.10 nm and the experimental being 0.0, giving a difference of 11 nm. 
Thereafter there is a death phase of 0.0 for the experimental. 
Figure 6 depicts the results of .23 nm concentration of the drug. 
This concentration also gives the widest range between the control and 
the experimental, it being 11 nm at 48 hrs. This concentration also 
undergoes a death phase from 48 to 120 hrs. 
The results of .28 mg/ml concentration of the drug are shown in 
figure 7. The 12-hr reading of this concentration shows that there is a 
FIG. 4 Growth of Tetrahymena pyriformis in 0.13 mg/ml Flurazepam 















FIG. 5 Growth of Tetrahymena pyriformis in 0.18 mg/ml Flurazepam 
dihydrochloride from 0 to 120 hrs at 540 nm. 
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FIG. 6 Growth of Tetrahymena pyriformis in 0.23 mg/ml Flurazepam 
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narrower difference between the control at .08 nm and the experimental 
at .05nm, giving a margin of 3 nm. At the 24-hr reading, the gap widens 
to 8 nm, with the control reading at .08 nm and the experimental at 
0.0 nm. The 48-hr reading increased to 9 nm. There was a stationary 
phase from 48 hrs to 96 hrs. The 120-hr reading also shows no activity 
with the experimental being at 0.0 nm. 
Figure 8 shows the concentration of .33 mg/ml of the drug. The 
differences between the experimental and the control at 12 hrs is 5 nm, 
at 48 hrs it is 10 nm, which was the largest margin, at 72 hrs, 96 hrs 
and 120 hrs the margin was 8 nm. 
The .38 mg/ml concentration observations are depicted in Figure 
9. There is only a 2 nm difference between the control and the 
experimental at 12 hrs. This increases to a 8 nm difference at 
48 hrs. At 72 hrs this increase drops to 7 nm with the experimental 
being .01 nm and the control being at .08 nm at 96 hrs and 120 hrs there 
is a 6 nm difference with the control being at .08 nm and the 
experimental being at .02 nm. 
Figure 10 gives the drug concentration of .43 mg/ml. The 12-hr 
reading shows the difference between experimental and control being 4 nm 
and the difference between 24 hrs increased to 7 nm, with the experi-
mental being .08 nm and the experimental being .02 nm. The 48-hr 
reading gives the widest margin of 9 nm. The 72-hr reading gives a 6 nm 
difference with the control being .08 nm and the experimental being 
.03 nm. The 120-hr reading shows an increase in differences to 7 nm by 
FIG. 7 Growth of Tetrahymena pyriformis in 0.28 mg/ml Flurazepam 















FIG. 8 Growth of Tetrahymena pyriformis in 0.33 mg/ml Flurazepam 
dihydrochloride from 0 to 120 hrs at 540 nm. 
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FIG. 9 Growth of Tetrahymena pyriformis in 0.38 mg/ml Flurazepam 
dihydrochloride from 0 to 120 hrs at 540 nm. 
• control 
• experimental 
.10 • . ~~. N 
CX> 
0.0. .06 .\ 
.02 ·-------- • ·-------- -------. • 
0 24 72 120 
TIME (HR) 
FIG. 10 Growth of Tetrahymena pYriformis in 0.43 mg/ml Flurazepam 

















1 nm with the control being .08 nm and the experimental reading dropping 
to .02 nm. 
Results of the .48 mg/ml concentration are shown in Figure 11. The 
12-hr reading showed a 4 nm difference between the control and the 
experimental. At 24 hrs the difference increases to 6 nm. It is still 
increasing at 48 hrs to 7 nm with the experimental showing .03 nm and 
the control showing .10 nm. The 72-, 96- and 120-hr readings have a 
margin of 6 nm, where the control shows .08 nm and the experimental 
shows .02 nm. 
The .53 mg/ml concentration is shown in Figure 12. the 48-hr 
reading shows a wide margin of 8 nm with the control showing .10 nm and 
the experimental showing .02 nm. 72-hr and 96-hr readings decrease 
their margins to show a 5 nm difference with the control being .08 nm 
and the experimental being .03 nm. The last reading of 120 hrs shows an 
increase to a 7 nm difference with the experimental showing a .01 nm 
reading and the control showing a .08 nm reading. 
Figure 13 shows the concentration of .58 mg/ml. The readings of 
the experimental results shows a stationary phase from 24 hrs to 96 
hrs. At the 120-hr reading there is an increase in the difference 
between the experimental and the control of 1 nm to 7 nm, where the 
experimental reading decreases to .02 nm and the control remains at 
.08 nm. 
The last drug concentration used was .63 mg/ml and it is shown in 
Figure 14. The margin between the experimental and the control is 2 nm 
at the first reading of 12 hrs. The margin increases to 5 nm at the 
FIG. 11 Growth of Tetrahymena pyriformis in 0.48 mg/ml Flurazepam 















FIG. 12 Growth of Tetrahymena pyriformis in 0.53 mg/ml Flurazepam 
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FIG. 13 Growth of Tetrahymena pYriformis in 0.58 mg/ml Flurazepam 
dihydrochloride from 0 to 120 hrs at 540 nm. 
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FIG. 14 Growth of Tetrahymena pyriformis in 0.63 mg/ml Flurazepam 














24-hr reading with the control result being .08 nm and the experimental 
result being .03 nm. The largest margin is shown at 48 hrs with the 
experimental being .03 nm and the control being .10 nm. At 72 and 
120 hrs a stationary phase is seen in both the experimental and the 
control. 
Light microscopic studies were used to determine the general 
effects of flurazepam dihydrochloride on tetrahymenas• motility. All 
organisms were exposed to flurazepam dihydrochloride with the same 
concentrations shown on Table II. Figure 15 shows an intact control 
cell of Tetrahymena pyriformis, showing the oral apparatus. Figure 16 
and Table IV depict the motility of Tetrahymena pyriformis was not 
reduced or stopped within the few readings between 0 and 25 mins. The 
results for the motility studies are shown in Figure 16. The drug 
concentrations used were 0.18 mg/ml, 23 mg/ml, .33 mg/ml, .43 mg/ml, .53 
mg/ml, and .63 mg/ml. No immobility was shown at 0.63 mg/ml until 25 
mins was reached, where there was a 27% immobility, with a steady 
increase to 80% immobility. Signs of immobility start to show at 0.53 
mg/ml and 0.43 mg/ml after 30 mins with a steady increase to 67% and 43% 
respectively. No percent immobi 1 ity was shown at 0.23 mg/ml until 45 
mins where the percent immobility was 6% with an increase to 25%. At 50 
mins, 0.18 mg/ml starts with a 5% immobilization with an increase 
thereafter to 20%. 
Figure 17 shows a typical Tetrahymena with the emphasis being on 
the rows of cilia and oral apparatus. The close up of the oral 
apparatus of Tetrahymena pyriformis is shown in Figure 18. The oral 
FIG. 15 Micrograph of a control cell . 
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FIG. 16 Graph of specific concentrations of Flurazepam dihydrochloride 
indicating the % immobilization of Tetrahymena pyriformis 
• .18 mg/ml 
a .23 mg/ml 
.&. .33 mg/ml 
fl .43 mg/ml 
o .53 mg/ml 





















Motility Experimental Study 
mg/ml TIME (MINUTES) 
5 10 15 20 25 30 35 40 45 50 55 60 
control 0 0 0 0 0 0 0 0 0 0 0 0 
.03 0 0 0 0 0 0 0 0 0 0 0 0 
.08 0 0 0 0 0 0 0 0 0 0 0 10 
.13 0 0 0 0 0 0 0 0 0 0 0 10 
.18 0 0 0 0 0 0 0 0 0 5 12 20 
• 23 0 0 0 0 0 0 0 0 0 5 14 20 
.28 0 0 0 0 0 0 0 0 6 12 20 25 
.33 0 0 0 0 0 0 0 0 6 13 20 27 
.38 0 0 0 0 0 0 8 10 19 25 31 35 
.43 0 0 0 0 0 0 11 11 22 30 37 40 
.48 0 0 0 0 0 12 12 19 27 35 40 43 
.53 0 0 0 0 0 20 25 30 38 46 50 55 
.58 0 0 0 0 0 35 31 48 50 55 60 67 
.63 0 0 0 0 27 40 40 45 50 60 70 80 
FIG. 17 Micrograph of the oral apparatus. 
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FIG. 18 Experimental micrograph of the oral apparatus of Tetrahymena 
pyriformis exposed to (0.33 mg/ml) Flurazepam dihydrochloride. 
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apparatus of Tetrahymena pYriformis in Figure 19 is an experimental 
result using the drug concentration of 0.33 mg/ml. Figure 20 depicts 
the contorted experimental concentration of 0.33 mg/ml of the entire 
Tetrahymena. 
0.63 mg/ml. 
Figure 21 shows two Tetrahymenae at the concentration of 
The drug having taken its effect on the tetrahymenae has 
perforated the membrane of one Tetrahymena and contorted the size of the 
other. 
FIG. 19 Experimental micrograph of Tetrahymena PYriformis exposed 0.33 
mg/ml Flurazepam dihydrochloride. 
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FIG. 20 Experimental micrograph of Tetrahymena pyriformis exposed 0.63 
mg/ml Flurazepam dihydrochloride. 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
Several limiting factors that must be considered when observing the 
effects of any drug on Tetrahymena pyriformis; (1) the time it would 
take for the drug to enter the cell, whether it is by the cell wall or 
by the oral apparatus, ( 2) the con cent ration of the drug, and ( 3) the 
depth of penetration. These three factors center around the fact that 
the cell membrane of Tetrahymena is very complex. For a number of 
different drugs the con cent ration required to reach a good penetration 
effect will have to be much higher for Tetrahymena than for mamma 1 ian 
cells. The cortex of Tetrahymena consists of a repeating unit of 
ciliary-kinetosome complex {basal body) with associated microtubules. 
Tetrahymena is enclosed in a system of membranes: the outer limiting 
membrane {outer pellicular membrane), the ciliary membrane, and the 
inner pellicular membrane. The last two membrane layers are connected 
by a series of cross bridges. (Hill, 1972). 
Nutrient entry into Tetrahymena may follow a variety of routes and 
employ a variety of mechanisms: (1) by diffusion (free, restricted, 
exchange, facilitated) through the cell membrane uniformly over the 
surface or a specific loci, and through the food vacuole membrane; and 
{2) by active transport, pinocytosis of phagocytosis at any of these 
locations. The paths and modes of entry depend upon the nature of the 
nutrient under consideration, the environmental circumstances, and the 
physiological state of the ciliate. Water, ions and small non polar 
44 
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molecules may traverse the surface by diffusion, active transport and 
pinocytosis. Macromolecules in solution and particulates can enter by 
pinocytosis and phagocytosis. Size, charge, lipoid solubility and the 
metabolic activities of the organism influence membrane permeation 
(Holtz, 1973). 
Dopamine is accumulated by cells of Tetrahymena pyriformis strain 
NT-1 and is secreted into their growth medium. These large amounts of 
dopamine was found to depend primarily upon extracellular non enzymatic 
conversion of tyrosine to L-Dihydroxyphenyl Alanine (L-Dopa). L-Dopa 
was then rapidly taken into cells and transformed into dopamine 
enzymatically. The origin of L-dopa came with the discovery that the 
enriched proteose peptone growth medium, though free of dopamine, 
contained high levels of L-dopa after being sterilized by autoclaving 
(Gunderson and Thompson, 1985; 1983). 
When observing the effects of the drug on the organism, the chem-
istry of the drug is an added parameter. Flurazepam dihydrochloride has 
a molecular weight of 408.826 (PRR 38th ed., 1984) and is readily 
soluble in water, with a short duration in the body because it is 
rapidly metabolized to 1-desalkyl-3-hydroxy flurazepam (de Silva and 
Strojny, 1971). The harmonic mean apparent half-life of flurazepam 
dihydrochloride is 2.3 hrs. Clinical observations show that flurazepam 
dihydrochloride is increasingly effective on the second and third night 
of consecutive use (Physicians Desk Reference 39th ed., 1985). 
The growth rate studies observed in this study were determined by 
turbidity measurements. Gross ( 1955) suggests that turbidity determi-
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nation is a very good method to ascertain density based on growth. In 
figures 2 through 14, in the growth studies, the effect of the drug on 
Tetrahymena shows that there is a peak at the first pay then a decrease 
until death occurs where there is a stabilizing effect. 
In Tetrahymena, cilia are known to possess axonemal ATPase, a 145 
and a 305 dynein. The surface membrane (pellicle) also has a fairly 
high activity of ATPase. In Arrhenius plots of 39°C grown cell prepa-
rations of this pellicle bound ATPase shows a break at about 27°C. 
However, treatment of the membrane with the local anesthetic, dibulaine, 
or the inhalation anesthetic, methoxyflurane, was observed to inhibit 
and lower the transition temperature of the ATPase activity to 21°C 
(Gibbons, 1966). Chua et al., in 1977, found that Ca2+-activated ATPase 
with a molecular weight of 89,000 was isolated from the cytosol of 
Tetrahymena pyriformis. The increase in cytosol ATPase activity in 
stationary growth phase suggests some role in cell division. It is also 
of great interest to note that this specific enzyme is different from 
ca2+-ATPase found in the nuclei, mitochondria, and microsomes. 
A body of evidence has accumu 1 a ted which indicates eye 1 i c AMP and 
GMP as regulators of many biological functions in the cell. Specifical-
ly, cell growth is known to be sensitively controlled by these cyclic 
nucleotides in a wide variety of cells (Pastan, et al., 1975), even in 
Tetrahymena (Wolfe, 1973; Dickinson et al., 1976). It was somewhat 
surprising to find a fairly high activity of adendylate cyclase in a 
free-living unicellular eukaryote, Tetrahymena pyriformis, which is 
apparently not exposed to the direct influence of hormones under its 
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normal growth conditions. However, the enzyme was observed to respond 
to epinephrine, and its stimulation by this hormone could be abolished 
by the a-adrenergic blocking agent, propranocol, but not by any 
a-adrenergic blocker (Rozensweig and Kinder, 1972). The membrane bound 
cyclase could be partially extracted by washing the membrane fraction 
with 0.25 M sucrose. The cyclase preparation treated with Triton X-100 
was no longer stimulated by epinephrine (Kassis and Kinder, 1975). It 
has been shown that a predominant enrichment of adenylate cyclase 
activity in the surface membrane (pellicle) as compared with the other 
membrane fractions in Tetrahymena pyriformis NT-1 (Shimonaka and Nozawa, 
1977). Since this enzyme is tightly associated with the pellicle 
membrane, it seems likely that alterations in membrane structure or 
composition may drastically change the properties of this enzyme. 
Indeed the specific activity of adenylate cyclase in ergositerol-
replaced pellicle was much lower than that observed in the native 
pellicle. In Arrhenius plots, a marked change in activity occurred at 
about 22°C, whereas there was a sharp discontinuity at 28°C to the 
vative pellicle containing Tetrahymena. These two temperatures are 
coincidental with the onset temperatures of membrane particle aggrega-
tion (phase separation) in the native and the sterol-replaced 
pellicle. This may indicate that the activity of adenylate cyclase is 
dependent upon the physi ca 1 state of the Tetrahymena surface membrane. 
In addition to adenylate cyclase mentioned above, guanylate cyclase was 
found in Tetrahymena (Gray et al., 1977), and was located in its surface 
membrane (Nozawa et al., 1979). Whereas guanylate clases from micro-
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organisms and mammalian tissue have been reported to require Mn 2+ as the 
sole metal cofactor with Mg 2+ as a very poor substitute, the cyclase of 
tetrahymena membranes was observed to prefer Mg2+ to Mn 2+ as a cofactor. 
Phenethyl alcohol (PEA) is known to affect the phospholipid and 
fatty acid metabolism in Escherichia coli and therefore, alters the 
phospholipid and its acyl chain composition of the cell membrane (Nunn, 
1975, 1977). Evidence shows that PEA inhibits phospholipid synthesis, 
primarily at the level of Sn-glycerol-3-phosphate acyltransferase and 
also that fatty acid synthesis would be inhibited as a secondary 
consequence of the altered phospholipid synthesis (Nunn, 1977). When 
tetrahymena cells were grown in the presence of 8 mM PEA, it was found 
that this drug induced a marked alteration in the relative proportions 
of both phospholipids and fatty acids in pellicles, mitochondria and 
microsomes (Nozawa et al., 1978}. 
The experimental results show that flurazepam dihydrochloride 
causes immobilization and decreased cell growth in Tetrahymena pyri-
formis. This may have been caused by the disruption of the cilia which, 
through their beating, brings the food to the buccal cavity (oral 
apparatus), where the food vacuoles form. This drug destroys the 
pellicle where the vacuoles from, therefore causing the organisms to 
eventually starve to death {total immobilization). 
Factors that influence the motility of cells also affect formation 
of the pattern of ci 1 i a. Under anaerobic conditions, the organism 
maintains its normal degree of motility at the expense of its glycogen 
reserves if an extern a 1 supply of glucose is not present. Much of the 
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(ATP) adenosinetriphosphate produced by Tetrahymena pyriformis is used 
for motility through the beating of the cilia. Evidence is available to 
show that a certain intracellular level ot ATP is required for the 
maintenance of motility (Warnock and Van Eys, 1963). 
Some inhibitors of motility are physostigmine and diisopropylfluo-
rophosphate, as well as hexamethonium and an antibody prepared from 
isolated cilia. Hexamethonium leads to a small increase in the intra-
cell u 1 a r A TP content. Its effect can be reversed by acetylcholine, 
which was once thought to be involved in impulse transmission along the 
rows of the cilia (Seaman and Houlihan, 1951). 
Dynein has been implicated on the mechanism of ciliary motility, 
since its presence is required for sensitivity of light-scattering 
properties of cilia to ATP (Gibbons, 1965). 
Colchicine and the inhibitors of protein synthesis block the 
regeneration of cilia. Colchicine exerts its effect without inhibiting 
either ribonucleic acid or protein biosynthesis. A suggested action of 
colchicine is that it interferes with the assembly of ciliary subunit 
proteins (Rosenbaum and Carlson, 1969). It has also been indicated that 
colchicine blocks the development of the oral structures (Nelsen, 1970}. 
Benzimidazoles, benzotriazoles and quinoxalines which contain a 
nitro group on the benzene ring are inhibitory to Tetrahymena pyriformis 
(Greer, 1958). 
The phenothiazine tranquilizer, chloropromazine, immobilizes 
Tetrahymena pyriformis and also increases its permeability. Test of a 
series of phenothiazines shows that alteration in permeability is 
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independent of the effectiveness of immobilization. The immobilization 
by chloropromazine is reversed by lecithin, Tween 80, and calcium ions 
(Nathan and Friedman, 1962}. 
The increased immobilization of Tetraphymena pyriformis by flura-
zepam di hydroch 1 ori de can eventually cause starvation for the micro-
organism and then eventually death. This immobilization causes the 
ciliary structures not to be formed or destroyed and thus causes the 
food not to be carried to the oral apparatus. The pellicular structures 
which form the cilia are destroyed causing the cilia to be destroyed. 
CHAPTER VI 
SUMMARY 
1. Flurazepam dihydrochloride at all concentrations tested reduced the 
growth rate of Tetrahymena pyriformis. Concentrations above 0.33 mg/ml 
were lethal to the organisms. 
2. Flurazepam dihydrochloride at 0.08 mg/ml after 60 min observations 
caused 20% immobilization. For the same amount of time 0.63 mg/ml were 
lethal to the organisms. There was 80% immobilization at 0.63 mg/ml. 
3. Scanning electron microscope studies revealed that the drug's effect 
is on the outer surfaces of the pellicle and the oral apparatus. 
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